Skip to main content
Clinical Trials/ISRCTN15931869
ISRCTN15931869
Active, not recruiting
Phase 2

A phase II feasibility trial of transcutaneous auricular vagus nerve stimulation for people with myalgic encephalomyelitis

niversity of Liverpool0 sites40 target enrollmentAugust 20, 2024

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Myalgic Encephalomyelitis (ME)
Sponsor
niversity of Liverpool
Enrollment
40
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 20, 2024
End Date
March 1, 2026
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Liverpool

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults with ME (as defined by the International Consensus Primer criteria for ME)
  • 2\. Mild to severe ME
  • 3\. Live in the Liverpool and Manchester region. The geographical restriction is to make the logistics and costs of visiting participants in their own home feasible

Exclusion Criteria

  • 1\. Previous or ongoing use of taVNS (as this study is evaluating first\-time use of taVNS)
  • 2\. Inability to stand (as this is part of the assessment procedure)
  • 3\. Contraindications to Tavns

Outcomes

Primary Outcomes

Not specified

Similar Trials